Opus Genetics, Inc. Common Stock (IRD) News

Latest headlines that mention IRD, newest first · each headline opens the original publisher

IRD quote

Last price: $3.32
Day change: -4.32%
Next earnings: 2026-11-11

Quote & chart Expected move Insider trading IV rank history

IRD headlines

latest coverage

Investing.com 6d ago

Opus Genetics at Chardan’s 10th annual healthcare conference: pipeline gains

General T3IRD

Investing.com 11d ago

Citizens reiterates Opus Genetics stock rating on cohort progress

General T3IRD

Seeking Alpha News 22d ago

Opus Genetics, Inc. (IRD) Presents at Euretina 2026 - Slideshow

General T2IRD

Investing.com 24d ago

Foundation fighting blindness fund sells $2.75m in Opus Genetics stock

General T3IRD

Seeking Alpha News 1mo ago

Opus Genetics: A Resounding Study Success Merits A Higher Valuation

General T2IRD

Seeking Alpha News 1mo ago

Opus Genetics, Inc. (IRD) Discusses Topline Results From Cohort 1 of BEST1 Phase I/II Gene Therapy Trial Transcript

General T2IRD

Seeking Alpha News 1mo ago

Opus Genetics, Inc. (IRD) Discusses Topline Results From Cohort 1 of BEST1 Phase I/II Gene Therapy Trial - Slideshow

General T2IRD

Investing.com 1mo ago

Wedbush raises Opus Genetics stock price target on FDA alignment

General T3IRD

Investing.com 1mo ago

Opus Genetics stock rating reaffirmed at Buy by H.C. Wainwright

General T3IRD

Yahoo Finance 1mo ago

Opus Genetics shares rise 5.9% ahead of OPGx-BEST1 trial data

General T2IRD

Investing.com 2mo ago

Citizens reiterates Opus Genetics stock rating on Viatris partnership potential

General T3IRD VTRS

Seeking Alpha 2mo ago

Opus Genetics GAAP EPS of -$0.14 beats by $0.02, revenue of $0.75M misses by $1.82M

Earnings T2IRD

Investing.com 3mo ago

Opus Genetics COO Joseph Schachle sells $13,653 in common stock

General T3IRD

Investing.com 3mo ago

Opus Genetics CEO George Magrath sells $27,925 in common stock

General T3IRD

Investing.com 3mo ago

Opus Genetics CFO Robert Gagnon sells $22,941 in company stock

General T3IRD

Investing.com 3mo ago

Form 144 Opus Genetics For: 23 July

General T3IRD

Investing.com 3mo ago

Opus Genetics stock holds Buy rating at BTIG on gene therapy progress

General T3IRD

Investing.com 3mo ago

B.Riley reiterates Buy on Opus Genetics stock on FDA alignment

General T3IRD

Yahoo Finance 3mo ago

RBC Capital Bullish On Opus Genetics (IRD) Amid Limited Competition And De-Risked Setup

General T2IRD

Investing.com 4mo ago

Opus Genetics stock rises after Russell index inclusion

General T3IRD

Investing.com 4mo ago

Opus Genetics to join Russell 2000 and Russell 3000 indexes

General T3IRD

Seeking Alpha News 4mo ago

Opus Genetics, Inc. (IRD) Discusses Early-Stage Gene Therapy Programs and Clinical Strategies for Inherited Retinal Diseases Transcript

General T2IRD

Investing.com 4mo ago

Citizens reiterates Opus Genetics stock rating on pipeline strength

General T3IRD

Seeking Alpha News 4mo ago

Opus Genetics, Inc. (IRD) Discusses Early-Stage Gene Therapy Programs and Clinical Strategies for Inherited Retinal Diseases - Slideshow

General T2IRD

Investing.com 4mo ago

Form 8K Opus Genetics Inc For: 16 June

General T3IRD

Yahoo Finance 4mo ago

Guggenheim Initiates Coverage Of Opus Genetics (IRD) With “Buy” Rating And $16 Price Target

General T2IRD

Investing.com 4mo ago

Form S-3 Opus Genetics Inc For: 5 June

General T3IRD

Seeking Alpha News 4mo ago

Opus Genetics: The Future Lies In The Success Of The AAV Delivery Platform

General T2IRD

Investing.com 5mo ago

Foundation fighting blindness fund sells $7.4m of Opus Genetics (IRD) stock

General T3IRD

Yahoo Finance 5mo ago

Here is Why Opus Genetics (IRD) is One of the Best Performing NASDAQ Stocks

Markets T2IRD

IRD news alerts

Get an alert by email or push when a new headline mentions IRD.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.